Teclison is a biotechnology company founded in 2014 with a mission to develop groundbreaking therapies for cancer. Specializing in the development of innovative cancer medicines, Teclison's approach focuses on inducing tumor necrosis and enhancing anti-tumor immunity for long-term cancer remission. The company's drug is designed to target any solid tumor with a predilection for liver metastasis, prioritizing hepatocellular carcinoma and metastatic colorectal cancer initially, with plans to expand to other solid tumors with liver metastasis. A first-in-class hypoxia-activating agent forms the basis of Teclison's novel approach, creating high local concentrations within tumors and producing profound hypoxia exclusively within the tumor. The company's latest milestone involves securing a $5.90M venture round investment on 14th February 2022, with participation from Nestor Capital and WTT Investment.
Teclison
Biotechnology company that specializes in the development of innovative cancer medicines
Montclair, United States
9 employees
Series Unknown
Total: $5.90M
Biotechnology
General Information
Get notified when Teclison moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Teclison
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
About Teclison
Taxonomy: cancer medicines, drug development, tumor necrosis, anti-tumor immunity, liver metastasis, hepatocellular carcinoma, metastatic colorectal cancer, hypoxia-activating agent, cancer cell targeting, cancer stem cells, tumor-promoting macrophages, novel therapies, oncology, pharmaceutical innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $5.90M | 2 |
|
14 Feb 2022 |
Teclison Alternatives & Competitors
DRIVEN TO CREATE NOVEL THERAPEUTICS TO TREAT AND PREVENT METASTASIS OF CANCER
-logo.jpg "Innovative Cellular Therapeutics (ICT)"){kind=logo}
Leading the fight against tumors with pioneering radiofrequency ablation technology
FAQ About Teclison
Don't just browse. Track.
Signal Tracker monitors Teclison and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.